Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.77 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.77 |
| ▸ | HPGD | P15428 | 1/20 | 0.77 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.77 |
| ▸ | GAA | P10253 | 1/20 | 0.76 |
| ▸ | NPC1 | O15118 | 1/20 | 0.76 |
| ▸ | RAB9A | P51151 | 1/20 | 0.76 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.73 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.71 |
| ▸ | MAPT | P10636 | 3/20 | 0.71 |
| ▸ | MEN1 | O00255 | 2/20 | 0.71 |
| ▸ | CA1 | P00915 | 1/20 | 0.70 |
| ▸ | CA2 | P00918 | 1/20 | 0.70 |
| ▸ | CA7 | P43166 | 1/20 | 0.70 |
| ▸ | CA9 | Q16790 | 1/20 | 0.70 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.70 |
| ▸ | HTT | P42858 | 1/20 | 0.68 |
| ▸ | NAMPT | P43490 | 1/20 | 0.65 |
| ▸ | PKM | P14618 | 1/20 | 0.65 |
| ▸ | POLB | P06746 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29356619 | 1.00 | ALDH1A1 (0.77) | ALDH1A1SMN1; SMN2HPGDALOX12GAA | |
| SCHEMBL7274134 | 0.95 | NPC1 (0.85) | ALDH1A1SMN1; SMN2HPGDALOX12GAA | |
| SCHEMBL14252956 | 0.92 | SMN1; SMN2 (0.77) | ALDH1A1SMN1; SMN2HPGDALOX12GAA | |
| SCHEMBL2775936 | 0.91 | ALDH1A1 (0.69) | ALDH1A1SMN1; SMN2HPGDALOX12GAA | |
| SCHEMBL11716101 | 0.90 | MTNR1B (0.68) | ALDH1A1SMN1; SMN2HPGDALOX12GAA | |
| SCHEMBL11717434 | 0.90 | NPC1 (0.66) | ALDH1A1SMN1; SMN2HPGDALOX12GAA | |
| SCHEMBL7115429 | 0.90 | GAA (0.70) | ALDH1A1SMN1; SMN2HPGDALOX12GAA | |
| SCHEMBL5726019 | 0.89 | ALDH1A1 (0.63) | ALDH1A1SMN1; SMN2HPGDALOX12GAA | |
| SCHEMBL4488518 | 0.88 | GAA (0.79) | ALDH1A1SMN1; SMN2HPGDALOX12GAA | |
| SCHEMBL28689186 | 0.88 | GAA (0.79) | ALDH1A1GAANPC1RAB9AMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114671729-B | Preparation method of aromatic ethylamine and derivative thereof | 南京大学 | 2023-04-25 | — | — | CN | disclosed |
| CN-114671729-A | Preparation method of aromatic ethylamine and derivatives thereof | 南京大学 | 2022-06-28 | — | — | CN | disclosed |
| CN-107540596-B | A kind of compound 5, the preparation method of 6- dihydroxy indole quinoline and its halogen acid salt | 烟台六谛医药科技有限公司 | 2019-06-14 | — | — | CN | disclosed |
| CN-107540596-A | A kind of preparation method of the dihydroxy indole quinoline of compound 5,6 and its halogen acid salt | 烟台六谛医药科技有限公司 | 2018-01-05 | — | — | CN | disclosed |
| US-20130012536-A1 | MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2013-01-10 | — | — | US | disclosed |
| US-20130012536-A1 | MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2013-01-10 | — | — | US | disclosed |
| US-20120035179-A1 | MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS | VERTEX PHARMACEUTICALS INCORPORATED | 2012-02-09 | — | — | US | disclosed |
| US-20100125090-A1 | Modulators of ATP-Binding Cassette Transporters | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2010-05-20 | — | — | US | disclosed |
| US-20100125090-A1 | Modulators of ATP-Binding Cassette Transporters | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2010-05-20 | — | — | US | disclosed |
| US-7598412-B2 | Modulators of ATP-binding cassette transporters | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2009-10-06 | — | — | US | disclosed |
| US-7598412-B2 | Modulators of ATP-binding cassette transporters | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2009-10-06 | — | — | US | disclosed |
| EP-1440052-B1 | BENZAMIDE DERIVATIVES AS ANTAGONISTS OF OREXIN RECEPTORS | SMITHKLINE BEECHAM PLC (GB) | 2005-12-14 | — | — | EP | disclosed |
| WO-1992000966-A1 | N-DIMETHOXY PHENYL ALKYL-N'-IMIDAZOLYL PHENYL AMIDINE DERIVATIVES AND PROCESS THEREOF | IL YANG PHARM. CO., LTD. (KR) | 1992-01-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130012536-A1 | MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS | ABCB11, ABCB1, ABCC5 | ALDH1A1 895/4885SMN1; SMN2 3617/4885HPGD 1656/4885 |
| US-20100125090-A1 | Modulators of ATP-Binding Cassette Transporters | ABCB11, ABCB1, ABCC5 | ALDH1A1 895/4885SMN1; SMN2 3617/4885HPGD 1656/4885 |
| US-20120035179-A1 | MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS | ABCB11, ABCB1, ABCC5 | ALDH1A1 895/4885SMN1; SMN2 3617/4885HPGD 1656/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.